Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
30-Sep-2026 | 560 | 561.25 | 536.65 | 541.7 | 32,010 | 31,15,93,240.65 | 3,93,160 |
01-Oct-2026 | 537.95 | 549 | 526.3 | 537.9 | 25,636 | 24,11,06,765.1 | 2,92,646 |
05-Oct-2026 | 534.85 | 559.5 | 532 | 553.6 | 19,940 | 14,47,09,100.3 | 1,67,596 |
06-Oct-2026 | 565.35 | 565.35 | 537.6 | 552.65 | 25,375 | 20,13,50,901.45 | 1,45,191 |
07-Oct-2026 | 550 | 550 | 539.15 | 541.45 | 6,549 | 6,49,46,249.45 | 62,577 |
08-Oct-2026 | 544.7 | 545.9 | 521.1 | 525.85 | 11,336 | 8,39,11,866.05 | 80,570 |
09-Oct-2026 | 525.85 | 532.5 | 516 | 529.25 | 12,434 | 5,72,82,038.8 | 48,515 |
12-Oct-2026 | 534.9 | 546 | 534.3 | 538.55 | 9,921 | 7,21,51,537.25 | 82,801 |
13-Oct-2026 | 538 | 543.15 | 530.3 | 534.75 | 21,063 | 15,40,10,559.85 | 1,84,403 |
14-Oct-2026 | 531 | 533.25 | 519.4 | 525.4 | 29,599 | 19,47,76,368.85 | 2,55,416 |
15-Oct-2026 | 526.9 | 548.95 | 517 | 523 | 11,178 | 13,18,48,669.45 | 1,39,829 |
16-Oct-2026 | 529.35 | 549.9 | 518.05 | 530.35 | 16,102 | 9,21,48,308.8 | 1,07,349 |
19-Oct-2026 | 533.4 | 534.45 | 512.6 | 519.1 | 7,500 | 7,43,03,171.1 | 93,133 |
21-Oct-2026 | 519.1 | 538.7 | 511.9 | 533.6 | 31,331 | 14,44,89,324.2 | 1,54,373 |
22-Oct-2026 | 526.45 | 535.95 | 511.6 | 530.6 | 27,732 | 15,91,81,654.2 | 1,58,522 |
23-Oct-2026 | 524 | 528.7 | 512.95 | 522.95 | 28,941 | 16,14,01,167.1 | 1,91,120 |
26-Oct-2026 | 515.55 | 534.95 | 515.55 | 530 | 11,832 | 4,03,93,075.15 | 36,208 |
27-Oct-2026 | 528.25 | 553 | 528.2 | 550.5 | 15,635 | 8,57,93,201.3 | 93,205 |
28-Oct-2026 | 552 | 563.4 | 545.2 | 551.2 | 15,785 | 11,49,90,114.45 | 97,088 |
29-Oct-2026 | 549.5 | 558 | 543.05 | 553.85 | 7,564 | 3,35,83,357.7 | 29,852 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
